Pancreatic cancer is considered one of the hardest to treat and most serious cancers

The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.

Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly…

Pancreatic cancer is considered one of the hardest to treat and most serious cancers